Earnings To Watch: Omada Health Inc (OMDA) Reports Q3 2025 Result

This article first appeared on GuruFocus.

Omada Health Inc (NASDAQ:OMDA) is set to release its Q3 2025 earnings on Nov 6, 2025. The consensus estimate for Q3 2025 revenue is $61.02 million, and the earnings are expected to come in at -$0.13 per share. The full year 2025's revenue is expected to be $238.76 million and the earnings are expected to be -$0.68 per share. More detailed estimate data can be found on the Forecast page.

Warning! GuruFocus has detected 8 Warning Signs with OSL:AZT.

Is OMDA fairly valued? Test your thesis with our free DCF calculator.

Revenue estimates for Omada Health Inc (NASDAQ:OMDA) have increased from $221.84 million to $238.76 million for the full year 2025 and increased from $266.57 million to $286.52 million for 2026 over the past 90 days. Earnings estimates have improved from -$0.78 per share to -$0.68 per share for the full year 2025 and from -$0.40 per share to -$0.31 per share for 2026 over the same period.

In the previous quarter ending on June 30, 2025, Omada Health Inc's (NASDAQ:OMDA) actual revenue was $61.37 million, which beat analysts' revenue expectations of $55.18 million by 11.23%. Omada Health Inc's (NASDAQ:OMDA) actual earnings were -$0.24 per share, which beat analysts' earnings expectations of -$0.30 per share by 20.13%. After releasing the results, Omada Health Inc (NASDAQ:OMDA) was down by 2.26% in one day.

Based on the one-year price targets offered by 9 analysts, the average target price for Omada Health Inc (NASDAQ:OMDA) is $28.33 with a high estimate of $31.00 and a low estimate of $24.00. The average target implies an upside of 11.72% from the current price of $25.36.

Based on GuruFocus estimates, the estimated GF Value for Omada Health Inc (NASDAQ:OMDA) in one year is $0.00, suggesting a downside of 100% from the current price of $25.36.

Based on the consensus recommendation from 9 brokerage firms, Omada Health Inc's (NASDAQ:OMDA) average brokerage recommendation is currently 2.1, indicating an \\"Outperform\\" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.

Scroll to Top